Pheochromocytoma physical examination

Jump to navigation Jump to search

Pheochromocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pheochromocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pheochromocytoma physical examination On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pheochromocytoma physical examination

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pheochromocytoma physical examination

CDC on Pheochromocytoma physical examination

Pheochromocytoma physical examination in the news

Blogs on Pheochromocytoma physical examination

Directions to Hospitals Treating Pheochromocytoma

Risk calculators and risk factors for Pheochromocytoma physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]

Overview

Common physical exam findings of pheochromocytoma include tachycardia, hypertension, and orthostatic hypotension.

Physical Examination

Appearance of the Patient

Vital Signs

  • Tachycardia with regular pulse. Irregular pulse occurs in supraventricular tachycardia.
  • Tachypnea / bradypnea if malignant secondaries found in lung
  • Rapid strong equal pulse
  • High blood pressure with normal pulse pressure
  • Hypotension occurs due to fluid contraction

Skin

  • Jaundice if liver malignant secondaries affected liver functions.

Head

  • Abnormalities of the head may include:
  • Facial flushing
  • Scleral icterus if liver malignant secondaries affected liver functions.
  • MEN2 patients associated with mucosal neuromas show multiple lips and tongue neuromas.

Neck

Lungs

  • Asymmetric chest expansion / Decreased chest expansion if malignant lung secondaries are found in lung

Heart

  • Chest tenderness upon palpation in MEN1 patients associated with hyperparathyroidism
  • Palpation: Pericordial heave especially at apex due to left ventricular hypertrophy in long standing patients
  • Auscultation: normal s1 and accentuated s2 due to high systemic resistance.

Abdomen

  • Abdominal distention in patients with primary hyperparathyroidism associated constioation or hirschsprung disease
  • Abdominal tenderness in the lower abdominal quadrants in MEN2 patients with hirschsprung disease[2]
  • A palpable abdominal mass in the lower abdominal quadrant
  • Guarding may be present
  • Hepatomegaly if malignant secondaries found in liver
  • Diarrhea caused by gastrointestinal secretion of fluid and electrolytes, and flushing in medullary thyroid cancer patients.[3]

Back

  • Point tenderness in MEN1 patients with hyperparathyroidism

References

  1. Wells SA, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF; et al. (2015). "Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma". Thyroid. 25 (6): 567–610. doi:10.1089/thy.2014.0335. PMC 4490627. PMID 25810047.
  2. O'Riordain DS, O'Brien T, Crotty TB, Gharib H, Grant CS, van Heerden JA (1995). "Multiple endocrine neoplasia type 2B: more than an endocrine disorder". Surgery. 118 (6): 936–42. PMID 7491537.
  3. Wells SA, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF; et al. (2015). "Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma". Thyroid. 25 (6): 567–610. doi:10.1089/thy.2014.0335. PMC 4490627. PMID 25810047.


Template:WikiDoc Sources